{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:31:25Z","timestamp":1792161085955,"version":"4.4.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long-COVID is a broadly defined condition and there are no effective therapies. Cardiovascular manifestations of long-COVID include high heart rate, postural tachycardia, and palpitations. Previous studies have suggested that mast cell activation (MCA) may play a role in the pathophysiology of long-COVID, including in the mechanisms of its cardiovascular manifestations. The present study aimed to evaluate the effectiveness of a treatment with blockers of histamine receptors in patients with long-COVID who did not respond to other therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In all, 14 patients (F\/M\u2009=\u20099\/5; 49.5\u2009\u00b1\u200911.5 years) and 13 controls (F\/M\u2009=\u20098\/5; 47.3\u2009\u00b1\u20098.0 years) with long-COVID symptoms attributed to MCA were evaluated. Patients were treated with fexofenadine (180\u2005mg\/day) and famotidine (40\u2005mg\/day). Fatigue, brain fog, abdominal disorders, and increased heart rate were evaluated in treated and untreated patients at baseline and 20 days later.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Long-COVID symptoms disappeared completely in 29% of treated patients. There was a significant improvement in each of the considered symptoms (improved or disappeared) in all treated patients, and the improvement grade was significantly greater in treated patients compared to controls. No significant differences in the outcomes were observed in the controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data confirm that histamine receptors blockade may be an effective target to successfully treat long-COVID. Our finding supports the underlying role of MCA in the pathophysiology of long-COVID.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2023.1202696","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:25:12Z","timestamp":1689578712000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation"],"prefix":"10.3389","volume":"10","author":[{"given":"Fabrizio","family":"Salvucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Codella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Zacchei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Anti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolita","family":"Nitisoara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Luzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Gazzaruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s10067-020-05239-5","article-title":"Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3390\/nu13082641","article-title":"The effects of COVID-19 on the eating habits of children and adolescents in Italy: a pilot survey study","volume":"13","author":"Pujia","year":"2021","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"n1648","DOI":"10.1136\/bmj.n1648","article-title":"Long COVID-mechanisms, risk factors, and management","volume":"374","author":"Crook","year":"2021","journal-title":"Br Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e36989","DOI":"10.2196\/36989","article-title":"Developing a long COVID phenotype for post-acute COVID-19 in a national primary care sentinel cohort: an observational retrospective database analysis","volume":"8","author":"Mayer","year":"2022","journal-title":"JMIR Public Health Surveill"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e2315","DOI":"10.1002\/rmv.2315","article-title":"Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies","volume":"32","author":"Yong","year":"2021","journal-title":"Rev Med Virol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1080\/07853890.2022.2076901","article-title":"Pathophysiology and mechanism of long COVID: a comprehensive review","volume":"54","author":"Castanares-Zapatero","year":"2022","journal-title":"Ann Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"103722","DOI":"10.1016\/j.ebiom.2021.103722","article-title":"Characterizing long COVID: deep phenotype of a complex condition","volume":"74","author":"Deer","year":"2021","journal-title":"EBioMedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"m3026","DOI":"10.1136\/bmj.m3026","article-title":"Management of post-acute COVID-19 in primary care","volume":"370","author":"Greenhalgh","year":"2020","journal-title":"Br Med J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect Dis (Lond)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3390\/cells10071761","article-title":"Cytokine storm syndrome in SARS-CoV-2 infections:a functional role of mast cells","volume":"10","author":"Hafezi","year":"2021","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijid.2020.09.016","article-title":"COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome","volume":"100","author":"Afrin","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijid.2021.09.043","article-title":"Mast cell activation symptoms are prevalent in long-COVID","volume":"112","author":"Weinstock","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jim-2021-002051","article-title":"Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines","volume":"70","author":"Glynne","year":"2022","journal-title":"J Investig Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1159\/000522498","article-title":"COVID-19 coagulopathy: from pathogenesis to treatment","volume":"145","author":"Alnima","year":"2022","journal-title":"Acta Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1016\/j.numecd.2020.07.040","article-title":"Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity","volume":"30","author":"Gazzaruso","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10067-020-05180-7","article-title":"High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia","volume":"39","author":"Gazzaruso","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"899198","DOI":"10.3389\/fphar.2022.899198","article-title":"Oxidative stress and hyper-inflammation as Major drivers of severe COVID-19 and long COVID: implications for the benefit of high-dose intravenous vitamin C","volume":"13","author":"Vollbracht","year":"2022","journal-title":"Front Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3390\/biomedicines10040812","article-title":"Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target","volume":"10","author":"Ambrosino","year":"2022","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/23744235.2022.2043560","article-title":"Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research","volume":"54","author":"Ceban","year":"2022","journal-title":"Infect Dis (Lond)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.aller.2016.04.015","article-title":"Histamine intolerance and dietary management: a complete review","volume":"44","author":"San Mauro Martin","year":"2016","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1249\/JES.0000000000000093","article-title":"The intriguing role of histamine in exercise responses","volume":"45","author":"Luttrell","year":"2017","journal-title":"Exerc Sport Sci Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"o988","DOI":"10.1136\/bmj.o988","article-title":"Are vaccines a potential treatment for long COVID?","volume":"377","author":"Sivan","year":"2022","journal-title":"Br Med J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.trsl.2015.12.012","article-title":"Cardiovascular symptoms in patients with systemic mast cell activation disease","volume":"174","author":"Kolck","year":"2016","journal-title":"Transl Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1042\/cs0910025supp","article-title":"Cardiovascular reflex changes preceding episodes of vasovagal syncope in paediatric subjects","volume":"91","author":"Bernardi","year":"1996","journal-title":"Clin Sci (Lond)"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1202696\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T07:25:14Z","timestamp":1689578714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1202696\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":24,"alternative-id":["10.3389\/fcvm.2023.1202696"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1202696","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]},"article-number":"1202696"}}